Trends of incidence and survival of gastrointestinal neuroendocrine tumors in the United States: a seer analysis.
about
Insights into gastric neuroendocrine tumors burdenManagement Options for Advanced Low or Intermediate Grade Gastroenteropancreatic Neuroendocrine Tumors: Review of Recent Literature.A population-based study of outcomes in patients with gastrointestinal neuroendocrine tumours.Recurrence 30 Years after Surgical Resection of a Localized Rectal Neuroendocrine Tumor.Factors associated with lymph node metastasis in radically resected rectal carcinoids: a systematic review and meta-analysis.Mutation-targeted therapy with sunitinib or everolimus in patients with advanced low-grade or intermediate-grade neuroendocrine tumours of the gastrointestinal tract and pancreas with or without cytoreductive surgery: protocol for a phase II clinicaFull-thickness excision using transanal endoscopic microsurgery for treatment of rectal neuroendocrine tumorsEndoscopic treatments for rectal neuroendocrine tumors smaller than 16 mm: a meta-analysis.High expression of the putative cancer stem cell marker, DCLK1, in rectal neuroendocrine tumors.Prognostic Significance of Defining L-Cell Type on the Biologic Behavior of Rectal Neuroendocrine Tumors in Relation with Pathological Parameters.Incidental neuroendocrine tumor of the appendiceal base less than20 mm in diameter: is appendectomy enough?Prospective Study of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and Unknown Primary SitesUpdate on management of midgut neuroendocrine tumors.Sequelae and survivorship in patients treated with (131)I-MIBG therapyA novel predictive model based on preoperative blood neutrophil-to-lymphocyte ratio for survival prognosis in patients with gastric neuroendocrine neoplasms.Endoscopic resection therapies for rectal neuroendocrine tumors: a systematic review and meta-analysis.Liver metastases from neuroendocrine tumors.Survival for oesophageal, stomach and small intestine cancers in Europe 1999-2007: Results from EUROCARE-5.Long-Term Clinical Outcomes of Rectal Neuroendocrine Tumors According to the Pathologic Status After Initial Endoscopic Resection: A KASID Multicenter Study.Imaging in neuroendocrine tumors: an update for the clinician.Inhibition of Peripheral Synthesis of Serotonin as a New Target in Neuroendocrine Tumors.Review article: the investigation and management of rectal neuroendocrine tumours.Mesenteric Tumor Deposits in Midgut Small Intestinal Neuroendocrine Tumors Are a Stronger Indicator Than Lymph Node Metastasis for Liver Metastasis and Poor Prognosis.Lymph Node Metastasis in the Prognosis of Gastroenteropancreatic Neuroendocrine Tumors.Improving survival prognostication of gastroenteropancreatic neuroendocrine neoplasms: Revised staging criteria.Real-world treatment patterns of gastrointestinal neuroendocrine tumors: A claims database analysis.Lower gastrointestinal neuroendocrine neoplasms associated with hereditary cancer syndromes: a case series.Nomogram based on tumor-associated neutrophil-to-lymphocyte ratio to predict survival of patients with gastric neuroendocrine neoplasms.Nomogram based on tumor-associated neutrophil-to-lymphocyte ratio to predict survival of patients with gastric neuroendocrine neoplasms.Chemotherapy in NETs: When and how.Metastatic small bowel neuroendocrine tumour with bilateral carcinoid heart disease.Clinical and functional implication of the components of somatostatin system in gastroenteropancreatic neuroendocrine tumors.Short- and long-term outcomes of endoscopic resection of rectal neuroendocrine tumours: analyses according to the WHO 2010 classification.Gastrointestinal carcinoid: epidemiological and survival evidence from a large population-based study (n = 25 531).Multiple Neuroendocrine Tumors in Stomach and Duodenum in a Multiple Endocrine Neoplasia Type 1 Patient.Feasibility of Radio-Guided Surgery with ⁶⁸Gallium-DOTATATE in Patients with Gastro-Entero-Pancreatic Neuroendocrine Tumors.Role of Staging in Patients with Small Intestinal Neuroendocrine Tumours.PROX1 is involved in progression of rectal neuroendocrine tumors, NETs.NKX2.2, PDX-1 and CDX-2 as potential biomarkers to differentiate well-differentiated neuroendocrine tumors.Incidence and survival of patients with small intestinal neuroendocrine tumours in a Danish NET center.
P2860
Q33649959-5842E903-89F9-492F-A795-EC389E684017Q33737587-9B49BA21-A03F-4D92-AC51-2FACF6158266Q33752497-28F1AD9C-4E46-41EE-B555-9C477E3AD4C6Q33894731-FB7A0ED5-78A2-4D6B-87BA-6F9FFFAA3D17Q34788991-5EE87B30-B24A-428F-9036-D665AB10F995Q35640506-CC3760E4-D5BA-4C3C-A9E6-7347DBF18BF0Q35942430-F39861D5-983F-4255-8C69-0D6EDA0E3E4CQ36066143-60E6CC19-2E9F-4463-8FFE-EB116258FCE0Q36085409-43087142-018E-43BA-ACE2-5062B0A0D310Q36187039-8C4010A1-25A2-4AED-918F-0DF404B19382Q36519615-2F6ABD48-8C5F-471C-99AA-B5BAAE21F75FQ36914468-B9139121-65DD-4CC0-B3AA-4190BB17FCA1Q37025143-988B242D-7C33-4F28-B1CB-B8345AAB9D4CQ37081870-6E75993C-28C0-4923-966F-664DE34DEF0DQ37520436-EC832995-2908-40B1-B894-E06C100A990BQ38151880-CCDB9290-59A2-45B8-A783-28CE563D64DEQ38283682-C1701026-FD09-412B-B8A9-B9C0910AD136Q38412185-0387E677-3685-462A-89E2-B975E3A60912Q38412977-22BDFC23-2593-482A-9EE6-6A5891C67E5AQ38563625-9421C68B-D8D8-44D0-B44D-C8681703A67CQ38815549-902AEC4D-3D37-4EA7-8949-2076253A7F33Q38865549-7DEE2A35-4060-4A45-A987-F4BE0F854046Q39339291-89BAF47E-9FB6-4039-84EF-CE7AFACC4340Q40043511-1DDB214A-F691-4300-BF4E-B60F24131356Q40277799-CE57553F-6023-42AC-A450-3E95D56F37F3Q42136049-BCEA374D-F522-4156-A218-A972F9C7C737Q46755855-248CA5EB-2890-4615-93E3-33112EAB89EBQ47125238-4FF02388-749D-4157-8EA5-A10FCCC16583Q47200269-57783644-5113-4CB5-9640-9FA35B9846E0Q47692261-750E0681-7349-4735-A193-E47592BC9A77Q47891547-FA1E87E5-41B1-4CF0-83DF-A7D406C7DDF7Q49352143-8CF9445F-9C64-4074-BEB3-B089C8985171Q50760995-5BB581F0-46A2-4A63-A183-476E1ED6A050Q51225473-9CAC68F5-B392-47D3-B08F-3E9178191A51Q52740193-17A05981-BDDF-44E9-B41E-1649CA59BC50Q52991087-428E7500-32CA-463E-99BF-D714B91E7795Q53336621-2CB1687B-14B4-4100-9627-BE78643A1F09Q53471841-13CD175C-6D66-4F96-BE40-0D1DB4F0B77EQ55313423-E8F8F05C-2547-434C-83CC-FBE58979C13BQ55395373-AC6CE0C0-6602-49B9-9724-8577B18C74F4
P2860
Trends of incidence and survival of gastrointestinal neuroendocrine tumors in the United States: a seer analysis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Trends of incidence and surviv ...... nited States: a seer analysis.
@ast
Trends of incidence and surviv ...... nited States: a seer analysis.
@en
type
label
Trends of incidence and surviv ...... nited States: a seer analysis.
@ast
Trends of incidence and surviv ...... nited States: a seer analysis.
@en
prefLabel
Trends of incidence and surviv ...... nited States: a seer analysis.
@ast
Trends of incidence and surviv ...... nited States: a seer analysis.
@en
P2093
P2860
P356
P1433
P1476
Trends of incidence and surviv ...... nited States: a seer analysis.
@en
P2093
Betsy C Wertheim
Marlon A Guerrero
Vassiliki L Tsikitis
P2860
P304
P356
10.7150/JCA.4502
P577
2012-07-01T00:00:00Z